OrbiMed Capital GP III LLC, 10% Owner at Roka BioScience, Inc. (ROKA), sold 14,300 shares at $1.50 ($21K) on 2017-08-24, disclosed to the SEC on 2017-08-25.
Open-market sale of $21k ROKA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 10 | $15 | 0.1% |
| 2 | $1.50 | 1,090 | $2K | 7.6% |
| 3 | $1.50 | 125 | $188 | 0.9% |
| 4 | $1.50 | 13,075 | $20K | 91.4% |
| Total | $1.50 avg | 14,300 | $21K | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |